Roche’s Spark Sues Rival Bluebird for Infringing Trademark

Roche’s Spark Therapeutics, a maker of gene-therapies for blood disorders, accused rival Bluebird Bio of using its trademarks without permission.

• Roche is seeking cash compensation and court orders blocking Bluebird from further unauthorized use of “Spark” marks, according to complaint filed Monday in federal court in Wilmington, Delaware
• One of Bluebird’s focuses is gene-therapy treatments for blood disorder sickle cell anemia, which is researched and treated by same doctors and scientists who work on hemophilia, complaint says
• Roche wants Bluebird to stop using and transfer to Spark the sparksicklecellchange.com domain and any others containing “Spark,” and that it abandon ...